Healthways (NASDAQ:HWAY) target price raised to $27.00, reported today by Barclays
- Updated: September 17, 2016
Boasting a price of $24.90, Healthways (NASDAQ:HWAY) traded 1.18% higher on the day. The last stock price close is up 76.76% from the two hundred day moving average, compared with the S&P 500 Index which has fallen -0.01% over the date range. Healthways has registered a 50-day moving average of $21.91 and 200-day moving average of $14.12. 572,865 shares of HWAY traded, down from ann average trading volume of 708,248
Healthways (NASDAQ:HWAY) had its price target bumped up to $27 by Barclays in a report announced Monday August 22 2016. The latest target price indicates a possible upside of 0.08% from the company’s previous stock close price.
On 8/12/2016, FBR Capital released a statement for Healthways(NASDAQ:HWAY) upped the target price from $21.00 to $28.00. At the time, this indicated a possible upside of 0.24%.
See Chart Below:
In addition to Barclays reporting it’s target price, a total of 6 analysts have issued a research note on Healthways. The consensus target stock price is $13.50 with two analysts rating the stock a strong buy, one analyst rating the stock a buy, four analysts rating the stock a hold, one analyst rating the stock to underperform, and finally 0 firms rating the stock as sell.
With a market cap of $0.0, Healthways has a price-earnings of 0 with a 52 week low of $9.18 and a 52 week high of $26.00.
Brief Synopsis On Healthways (NASDAQ:HWAY)
Healthways, Inc. (Healthways) provides network delivered solutions and population health management services that are designed to help people manage their wellbeing, thereby managing their health and productivity, and their health-related costs. The Company operates in the domestic and international segments, which are collectively known as the well-being improvement services segment. The Company engages entire populations, including health plan memberships, workforces and communities, while in other cases it engages targeted populations, such as members at high-risk, cohorts of cardiac rehabilitation patients or hospital discharge patients. In the United States, it operates in approximately 50 states and the District of Columbia. Its customers include health plans, both commercial and Medicare Advantage, large self-insured employers, including state and municipal government entities, and providers of healthcare, including integrated healthcare systems, and and hospitals.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.